CN1857377A - Preparation and application of total safflower flavone composition - Google Patents
Preparation and application of total safflower flavone composition Download PDFInfo
- Publication number
- CN1857377A CN1857377A CN 200610046077 CN200610046077A CN1857377A CN 1857377 A CN1857377 A CN 1857377A CN 200610046077 CN200610046077 CN 200610046077 CN 200610046077 A CN200610046077 A CN 200610046077A CN 1857377 A CN1857377 A CN 1857377A
- Authority
- CN
- China
- Prior art keywords
- total
- flavone
- radix paeoniae
- content
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of compound preparation with total safflower flavone composition as main component and for treating cardiac and cerebral vascular diseases. The composition consists of total safflower flavone 1-99 wt%, and total sowthistle-leaf ixeris flavone, total astragalus flavone, or total peony glycoside 1-99 wt%, and is compounded with proper amount of pharmaceutically acceptable supplementary material to form various kinds of preparation forms. The medicine of the present invention is used in preventing and treating cardiac and cerebral vascular diseases, senile dementia, cerebral infarction and other cardiac and cerebral vascular diseases.
Description
Technical field:
The present invention relates to a kind of compound preparation of the treatment cardiovascular and cerebrovascular disease based on total safflower flavone composition.And the application of various preparations in pharmaceutical field that utilizes the inventive method to obtain, the particularly application in the medicine of preparation control cardiovascular and cerebrovascular disease, senile dementia, cerebral infarction, cerebral ischemia and other various diseases of causing by cerebral ischemia thereof etc.Make a distinction between the important and the lesser one in the full side of medicine of the present invention, compatibility is proper, and complementation is short mutually.
Background technology:
Flos Carthami, Herba Ixeritis Sonchifoliae, the Radix Astragali, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Fructus Hippophae etc. all are China's conventional Chinese medicines, and its medicine as the treatment cardiovascular and cerebrovascular disease has basis of clinical application widely and long clinical application history, and evident in efficacy.Modern pharmacology studies show that Flos Carthami total flavone has effects such as coronary artery dilator, coronary blood flow increasing, microcirculation improvement, blood fat reducing, blood pressure lowering; Herba Ixeritis Sonchifoliae total flavones has effects such as blood vessel dilating, blood flow increasing, blood viscosity lowering, quickening blood flow rate, anti-hypoxia; Radix Astragali total flavones and total saponins thereof have the myocardium shrinkage function of improvement, dwindle myocardial infarction area, alleviate myocardial damage, improve myocardial ischemia, protect effects such as cardiovascular and cerebrovascular vessel, microcirculation improvement, antiviral property myocarditis; Peoniflorin have promote learning memory disorder due to learning and memory, the antagonism scopolamine, significantly improve learning memory disorder due to the cerebral ischemia re-pouring, improve effects such as body microcirculating state, blood viscosity lowering, the inductive platelet aggregation of inhibition ADP.Modern clinical research shows that Fructus Hippophae total flavones has curative effect preferably for angina pectoris, coronary heart disease.
How to overcome the shortcoming of taking single medicinal material, reasonable compatibility, short complementary mutually, make it to become effective good recipe of treatment diseases of cardiovascular and cerebrovascular systems, making it to bring into play the best use of at aspect such as improve cardio-cerebrovascular function and control aging of brain, raise immunity, slow down aging, improve the quality of living is its maximum difficult point.
Summary of the invention:
The objective of the invention is defective and deficiency at above-mentioned prior art existence, provide a kind of and can overcome the shortcoming of taking single medicinal material, reasonable compatibility, short complementary mutually, make it to become effective good recipe of treatment diseases of cardiovascular and cerebrovascular systems, make it that the best use of is brought into play in the aspect improving cardio-cerebrovascular function and control aging of brain, raise immunity, slow down aging, improve the quality of living etc.
The compositions that further aim of the present invention provides Flos Carthami total flavone (is the compositions of Flos Carthami total flavone and Herba Ixeritis Sonchifoliae total flavones, Flos Carthami total flavone and Radix Astragali total flavones and total astragalin composition, the compositions of Flos Carthami total flavone and Radix Paeoniae Alba total glycosides, the compositions of Flos Carthami total flavone and Fructus Hippophae total flavones) and the application of preparation in pharmaceutical field, particularly be used to prevent and treat other dysfunction that cardiovascular and cerebrovascular disease, senile dementia, cerebral ischemia cause, the medicine of the anti-ageing disease of waiting for a long time in preparation.
The present invention is implemented by following technical proposals.
The present invention relates to a kind of is the method for the compound preparation of main preparation control cardiovascular and cerebrovascular disease, senile dementia, cerebral ischemia and other various diseases of being caused by cerebral ischemia thereof etc. by total safflower flavone composition, it is characterized in that this method comprises following content:
(1) calculates according to composition by weight and get 99～1 parts of 1～99 part of Flos Carthami total flavone (content of total flavone is 20%～100% in the total flavones) and Herba Ixeritis Sonchifoliae total flavones and saponin (content of total flavone is 20%～100% in the Herba Ixeritis Sonchifoliae total flavones) respectively, respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(2) calculate according to composition by weight and get 1～99 part of Flos Carthami total flavone (content of total flavone is 20%～100% in the total flavones) and Radix Astragali total flavones and total saponins respectively (content of total flavone is 30%～90% in the Radix Astragali total flavones, the content of total saponins is 10%～90%) 99～1 parts, respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(3) calculate according to composition by weight and get 1～99 part of Flos Carthami total flavone (content of total flavone is 20%～100% in the total flavones) respectively and Radix Paeoniae Alba total glycosides (comprises Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides, wherein the content of Radix Paeoniae Alba total glycosides is 20%～100%) 99～1 parts, respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(4) calculate according to composition by weight and get 99～1 parts of 1～99 part of Flos Carthami total flavone (content of total flavone is 20%～100% in the total flavones) and Fructus Hippophae total flavoness (content of total flavone is 20%～100% in the Fructus Hippophae total flavones) respectively, respectively or mix the suitable adjuvant of back adding such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
The specific embodiment
The following examples can help those skilled in the art more fully to understand the present invention.But do not limit the present invention in any way.
Embodiment 1 Flos Carthami Ixers sonchifolia freeze-dried powder
Get Flos Carthami total flavone 1.0g respectively, Herba Ixeritis Sonchifoliae total flavones 3.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 2 Flos Carthami Radix Paeoniae freeze-dried powders
Get Flos Carthami total flavone 1.5g respectively, Radix Paeoniae Alba total glycosides 3.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 3 Flos Carthami Radix Astragali freeze-dried powders
Get Flos Carthami total flavone 1.5g respectively, Radix Astragali total flavones 2.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 4 safflower seabuckthorn freeze-dried powders
Get Flos Carthami total flavone 1.5g respectively, Fructus Hippophae total flavones 2.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 5 Flos Carthami Herba Ixeritis Sonchifoliae capsules
Get Flos Carthami total flavone 10g respectively, Herba Ixeritis Sonchifoliae total flavones 35g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 6 Flos Carthami Radix Paeoniae capsules
Get Flos Carthami total flavone 10g respectively, Radix Paeoniae Alba total glycosides 35g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 7 safflower yellow astragalus capsules
Get Flos Carthami total flavone 10g respectively, Radix Astragali total flavones 30g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 8 safflower seabuckthorn capsules
Get Flos Carthami total flavone 10g respectively, Fructus Hippophae total flavones 40g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
The extraction of embodiment 9 Herba Ixeritis Sonchifoliae total flavoness, Flos Carthami total flavone, Fructus Hippophae total flavones, Radix Astragali total flavones
(1) take by weighing Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or variable concentrations alcohol (comprising ethanol, methanol etc.) extract 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.Concentrate with suitable quantity of water dissolving (100～1000ml), with organic solvent degreasing (comprise petroleum ether, chloroform, etc., hyposynchronization also can save), extractions such as ethyl acetate or n-butyl alcohol or n-amyl alcohol, get final product behind the recovery organic solvent the total flavones crude product.
(2) take by weighing Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, add 6～10 times of water gagings, regulate pH to 8～9, decocted 0.5～3 hour, filter, extract so repeatedly 1～3 time with lime cream.Merge extractive liquid, is chilled to below 70 ℃, regulates pH to 3～5 with acid (comprising mineral acid and organic acid such as acetic acid, trichloroacetic acid such as hydrochloric acid, sulphuric acid), and is static, filter get final product the total flavones crude product.
(3) take by weighing Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or different concentration ethanol are extracted 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), (comprise polarity, middle polarity and nonpolar macroporous adsorption resin through the separation of macroporous adsorbent resin chromatography post, the ratio of the consumption of resin and crude drug is 1: 0.2～5), water, different concentration ethanol or methanol-eluted fractions successively, collect different concentration ethanol or methanol-eluted fractions fraction, reclaim get final product behind the solvent the different total flavones elaboration of purity.The total flavones crude product that obtains in above-mentioned (1 and 2) also can be by macroporous adsorbent resin chromatography post refining (method be the same).
(4) take by weighing Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or different concentration ethanol are extracted 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), separate through the polyamide chromatographic column, water, different concentration ethanol or methanol-eluted fractions are collected different concentration ethanol or methanol-eluted fractions fraction successively, reclaim get final product behind the solvent the different total flavones elaboration of purity.The total flavones crude product that obtains in above-mentioned (1 and 2) also can be by polyamide chromatographic column refining (method be the same).
The extraction of embodiment 10 Radix Paeoniae Alba total glycosides
(1) take by weighing Radix Paeoniae 1Kg, water or variable concentrations alcohol (comprising ethanol, methanol etc.) extract 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.Concentrate with suitable quantity of water dissolving (100～1000ml), with organic solvent degreasing (comprise petroleum ether, chloroform, ethyl acetate etc., hyposynchronization also can save), n-butanol extraction (comprising n-amyl alcohol etc.), reclaim get final product behind the n-butyl alcohol saponin slightly.
(2) take by weighing Radix Paeoniae 1Kg, water or different concentration ethanol are extracted 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), (comprise polarity, middle polarity and nonpolar macroporous adsorption resin through the separation of macroporous adsorbent resin chromatography post, the ratio of the consumption of resin and crude drug is 1: 0.2～5), water, different concentration ethanol eluting successively, collect the different concentration ethanol eluting fraction, get final product the different total saponins elaboration of purity.The thick total saponins that obtains in above-mentioned (1) also can be by macroporous adsorbent resin chromatography post refining (method be the same).
Claims (9)
1, a kind of total safflower flavone composition, it is characterized in that being grouped into (percentage by weight): Flos Carthami total flavone 1%～99%, Herba Ixeritis Sonchifoliae total flavones and saponin 99%～1% or Radix Astragali total flavones and total saponins 99%～1% or Radix Paeoniae Alba total glycosides (comprising Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides) 99%～1% or Fructus Hippophae total flavones 99%～1% by following one-tenth.More particularly, be meant in Flos Carthami total flavone and the said medicine combination of any one or two or more medicines, be equipped with proper pharmaceutical excipients and make the pharmaceutically various preparations of acceptable.
2, according to right 1 described preparation, it is characterized in that: content of total flavone is 20%～100% in the Flos Carthami total flavone in the described composition.
3, according to right 1 described preparation, it is characterized in that: content of total flavone is 20%～100% in the Herba Ixeritis Sonchifoliae total flavones in the described composition, and saponin content is 0.5%～100%.
4, according to right 1 described preparation, it is characterized in that: content of total flavone is 30%～90% in Radix Astragali total flavones in the described composition and the total saponins, and the content of total saponins is 10%～90%.
5, according to right 1 described preparation, it is characterized in that: the content of the Radix Paeoniae Alba total glycosides in the Radix Paeoniae Alba total glycosides in the described composition (comprising Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides) is 20%～100%.
6, according to right 1 described preparation, it is characterized in that: content of total flavone is 20%～100% in the Fructus Hippophae total flavones in the described composition.
7, according to right 1 described preparation of compositions method, it is characterized in that: it is the characteristics according to various compositionss, and the modern preparation technique that allows on the employing pharmaceutics is realized.
8, all kinds of preparations of making according to right 1 described compositions, it is characterized in that: it comprises injection type, peroral dosage form, percutaneous dosing dosage form, mucosa absorption dosage form.
9, all kinds of preparations of making according to right 1 described compositions is characterized in that: be mainly used in other dysfunction, the anti-ageing disease of waiting for a long time that control cardiovascular and cerebrovascular disease, senile dementia, cerebral infarction, cerebral ischemia cause.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610046077 CN1857377A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total safflower flavone composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610046077 CN1857377A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total safflower flavone composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1857377A true CN1857377A (en) | 2006-11-08 |
Family
ID=37296365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610046077 Pending CN1857377A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total safflower flavone composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1857377A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103505497A (en) * | 2012-06-28 | 2014-01-15 | 天津天狮生物发展有限公司 | Traditional Chinese medicine composition containing rosewood and preparation method of composition |
| CN110623998A (en) * | 2019-09-11 | 2019-12-31 | 中国中医科学院中医临床基础医学研究所 | Traditional Chinese medicine composition for diabetic peripheral neuropathy and application thereof |
| CN114869928A (en) * | 2022-04-27 | 2022-08-09 | 中国人民解放军空军军医大学 | Traditional Chinese medicine composition for treating cerebrovascular diseases and application thereof |
-
2006
- 2006-03-17 CN CN 200610046077 patent/CN1857377A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103505497A (en) * | 2012-06-28 | 2014-01-15 | 天津天狮生物发展有限公司 | Traditional Chinese medicine composition containing rosewood and preparation method of composition |
| CN110623998A (en) * | 2019-09-11 | 2019-12-31 | 中国中医科学院中医临床基础医学研究所 | Traditional Chinese medicine composition for diabetic peripheral neuropathy and application thereof |
| CN114869928A (en) * | 2022-04-27 | 2022-08-09 | 中国人民解放军空军军医大学 | Traditional Chinese medicine composition for treating cerebrovascular diseases and application thereof |
| CN114869928B (en) * | 2022-04-27 | 2023-06-06 | 中国人民解放军空军军医大学 | Traditional Chinese medicine composition for treating cerebrovascular diseases and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857473A (en) | Gynostemma pentaphylla saponin composition preparation and its preparing process | |
| CN101119740B (en) | Use of radix sanguisorbae and its extract for preparing medicament to increase RBC and hemoglobin | |
| CN1857388A (en) | Preparation and application of notoginseng stem and leaf total saponin composition | |
| CN1857472A (en) | Ginsenoside composition preparation and its preparing process | |
| CN1833692A (en) | False portulaca oleracea extracts, its prepn. and usage | |
| CN109464514A (en) | A kind of capejasmine extract that treating hyperbileacidemia and its preparation and application | |
| CN102134268B (en) | Method for preparing panax japonicus saponin IVa and application of panax japonicus saponin IVa in preparing a medicament for protecting liver and lowering transaminase | |
| CN1857441A (en) | Preparation and application of total salvianolic acid composition | |
| CN100534508C (en) | Method for extracting effective sites group of smilax China root | |
| CN102274260B (en) | Medicinal composition of notoginseng root extract and preparation method thereof | |
| CN1314403C (en) | Composition of paeoniflorin and albiflorin and its preparation method | |
| CN1857377A (en) | Preparation and application of total safflower flavone composition | |
| CN1857442A (en) | Preparation and application of ligustrazine and its salt composition | |
| CN1973853B (en) | Hemostatic and analgetic medicine composition and its preparation process | |
| CN1857469A (en) | Arasaponin composition preparation and its preparing process | |
| CN100536868C (en) | Powder injection contg high content tanshin polyphenolic acid salts, and its preparation method | |
| CN100484557C (en) | Chinese medicine compound preparation for treating myocardial ischemia and improving microcirculation, and preparing method thereof | |
| CN1857395A (en) | Compound Chinese medicine composition for treating cardiac and cerebral vascular diseases | |
| US20100158864A1 (en) | Antiviral product | |
| CN1857439A (en) | Preparation and application of ginkgo leaf flavonid composition | |
| CN100431566C (en) | Chinese medicine composition and its prepn process and application | |
| CN1686200A (en) | Tulip poplar extract, refined extract and its application in medicine preparation | |
| CN105640970B (en) | Effective part of ginseng stem and leaf and preparation method and application thereof | |
| CN1836665A (en) | Pharmaceutical uses of hesperidin or its composition | |
| CN1857443A (en) | Preparation and application of astragalus flavonid and total astragalin composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |